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Background: Tuberculosis (TB) still remains one of the most deadly infectious diseases in the world. Mycobacterium
tuberculosis β-ketoacyl-ACP Reductase (MabA) is a member of the fatty acid elongation system type II, providing
precursors of mycolic acids that are essential to the bacterial cell growth and survival. MabA has been shown to be
essential for M. tuberculosis survival and to play a role in intracellular signal transduction of bacilli.
Findings: Here we describe site-directed mutagenesis, recombinant protein expression and purification,
steady-state kinetics, fluorescence spectroscopy, and molecular modeling for S140T and S140A mutant MabA
enzymes. No enzyme activity could be detected for S140T and S140A. Although the S140T protein showed
impaired NADPH binding, the S140A mutant could bind to NADPH. Computational predictions for NADPH binding
affinity to WT, S140T and S140A MabA proteins were consistent with fluorescence spectroscopy data.
Conclusions: The results suggest that the main role of the S140 side chain of MabA is in catalysis. The S140 side
chain appears to also play an indirect role in NADPH binding. Interestingly, NADPH titrations curves shifted from
sigmoidal for WT to hyperbolic for S140A, suggesting that the S140 residue may play a role in displacing the
pre-existing equilibrium between two forms of MabA in solution. The results here reported provide a better
understanding of the mode of action of MabA that should be useful to guide the rational (function-based)
design of inhibitors of MabA enzyme activity which, hopefully, could be used as lead compounds with
anti-TB action.
Keywords: Mycobacterium tuberculosis, β-Ketoacyl-ACP Reductase, MabA, Site-directed mutagenesis, Enzyme
activity, Fluorescence spectroscopy, Molecular modelingFindings
Background
Tuberculosis (TB) remains the leading cause of mortality
due to a bacterial pathogen, Mycobacterium tuberculosis
[1]. In 2008, there were an estimated 8.9-9.9 million inci-
dent cases of TB, killing two million people annually [2].
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reproduction in any medium, provided the ormulti-drug resistant TB (MDR-TB), which is defined as
strains resistant to, at least, isoniazid and rifampicin [2].
The emergence of extensively drug-resistant (XDR-TB)
TB cases, defined as cases in persons with TB whose iso-
lates are MDR that are also resistant to a fluoroquino-
lone and, at least, one second-line injectable agent
(amikacin, kanamycin and/or capreomycin) [2,3], its
widespread distribution [4], and unprecedented fatality
rate [5], raise the prospect of virtually incurable and
deadly TB worldwide. Recently, a total new strain was
identified as resistant to all first and second line of anti-
TB drugs tested [6,7]. There is thus is an urgent need
for the development of new antimycobacterial agents.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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present in bacteria, plants and organisms of the phylum
Apicomplexa, but generally considered to be absent
from mammals. M. tuberculosis mabA(fabG1)–encoded
β-ketoacyl-ACP Reductase (MabA) is a member of
FAS-II system, which elongates acyl fatty acid precursors
yielding the long carbon chain of the meromycolate
branch of mycolic acids, the hallmark of mycobacteria
[8]. It has been shown that MabA is essential for
M. tuberculosis survival [9]. Post-translational phosphor-
ylation of MabA by Ser/Thr protein kinase activity has
been shown to negatively regulate mycolic acid biosyn-
thesis [10]. The dehydratases of M. tuberculosis FAS-II
(HadAB and HadBC) and methyltransferases have re-
cently been shown to be part of a mycolic acid biosyn-
thesis interactome, which is involved in coordinating
elongation and chemical modification of mycolic acids
[11]. For enzyme-targeted drug programs, however,
mechanistic analysis should always be a top priority be-
cause effective enzyme inhibitors take advantage of en-
zyme chemistry to achieve inhibition [12]. As MabA
represents a possible target for anti-tubercular agent de-
velopment, the work here described was undertaken.
MabA belongs to the family of short-chain dehydro-
genases/Reductase (SDR) [13], displaying a preference
for NADPH over NADH, and higher specificity for long
β-ketoacyl chains [14]. Crystal structure of MabA
revealed a conserved Rossmann fold and the Ser-Tyr-Lys
catalytic triad conserved among SDR members [15]. The
conserved catalytic triad of MabA corresponds to the
following signature: S140(X)12Y153(X)3 K157. The cata-
lytic triads of SDR proteins catalyze abstraction of the
proton from the substrate grouping H-C-O-H, although
they also catalyze reduction of C = C and C = N double
bonds, and mediate dehydratase, as well as sulfotransfer-
ase, isomerase, and decarboxylation reactions [16]. The
dependence of MabA initial velocity on pH values has
identified a single enzyme group with a pKa value of 9.6
that abolishes activity upon deprotonation, which has
been proposed to likely be either Tyr or Lys component
of the Ser-Tyr-Lys triad [17]. However, it has been sug-
gested that the Ser138 of the catalytic triad plays a cata-
lytic role in Drosophila alcohol dehydrogenase, an SDR
protein [18]. On the other hand, the Ser residues of the
catalytic triad of SDR proteins have been suggested to
play a minor role, if any, in catalysis [19]. Analysis of
MabA crystal structure in the apo form showed a 90° ro-
tation of Tyr153 phenol ring that was proposed to be
induced by the hydroxyl group of “catalytic” Ser140 [15].
In this particular arrangement, S140 is placed into the
position occupied by the nicotinamide ribose of NADP
in the holo-form [15]. However, there has been no re-
port on the role, if any, of S140 in the mode of binding
and/or catalysis of MabA.Side-directed mutagenesis, recombinant protein expression
and purification
To evaluate the role of S140 residue in MabA, S140T and
S140A mutants were produced by site-directed mutagen-
esis. The singly mutated genes corresponding to S140T
and S140A were generated using the Quick Change Site-
Directed Mutagenesis Kit (Stratagene) according to the
manufacturer’s instructions and pET23a(+):mabA as the
template. The mutant genes were sequenced in their en-
tirety to ensure that no unexpected mutations occurred.
The recombinant plasmid was transformed into Escheri-
chia coli BL21(DE3) cells (Novagen) and grown in Luria-
Bertani medium 50 g mL-1 carbenicillin, at 37°C to a
value of 0.4 for absorbance at 600 nm, and induced by
the addition of isopropyl-1-thio-β-D-galactopyranoside
(IPTG) to a final concentration of 0.1 mM. Cells were
allowed to grow for an additional 4 h and harvested by
centrifugation at 20,800 g for 30 min. Soluble S140T and
S140A mutant MabA proteins were purified to homo-
geneity as described elsewhere [17,20]. Samples of the
purification steps were analyzed by SDS-PAGE [21] and
protein content by the Bradford’s method [22].
Steady-state kinetics measurements
Activity assays of homogeneous S140T and S140A mutant
enzymes were carried out under steady-state conditions at
25°C and 100 mM HEPES, pH 7.0, measuring decrease in
absorbance at 370 nm (E = 2,320 M-1 cm-1) upon oxida-
tion of NADPH (1.5 – 6 mM) in the presence of
acetoacetyl-CoA (AcAcCoA: 2 – 8 mM). These concentra-
tions are well above the KM values for NADPH (26 μM)
and AcAcCoA (165 μM) [17]. In addition, increasing mu-
tant enzyme concentrations (0.48 μM ≤ S140T ≤ 3.45 μM;
0.36 μM ≤ S140A ≤ 2.6 μM) were tested to try to detect
β-ketoacyl Reductase activity, if any. The S140T and
S140A mutants had no detectable activity under these
experimental conditions.
Fluorescence spectroscopy
To ascertain whether these mutations affected catalysis
or substrate binding, enhancement in nucleotide fluores-
cence upon NADPH binding to MabA was employed to
evaluate the overall dissociation constant for binary
complex formation at equilibrium (Kd), as previously
described [20]. Fluorescence titration of NADPH bind-
ing to either S140T or S140A mutants at equilibrium
was carried out at 25°C by making micro liter additions
of 10 mM NADPH to 2 mL of 4 μM mutant protein in
100 mM Hepes, pH 7.0, keeping the dilution to a max-
imum of 0.75%. Nucleotide fluorescence excitation and
emission wavelengths were, respectively, 360 and
520 nm (maximum λem = 460 nm). The slits for excita-
tion and emission were, respectively, 1.5 and 5 nm. Con-
trol measurements were performed under the same
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values were subtracted from those obtained in the pres-
ence of the enzyme. This control was also employed to de-
termine the maximum NADPH concentration to be
utilized with no significant inner filter effect. Data were
plotted as Δ relative fluorescence versus NADPH concen-
tration (4.99 – 123.45 μM for S140T, and 4.99 - 39.83 μM
for S140A). Larger values for NADPH concentrations
could not be used due to significant inner filter effect. No
binding of NADPH to S140T mutant protein could be
detected (Figure 1 - inset), indicating a Kd value larger
than 123 μM. This result suggests that the S140T change
resulted in impaired substrate binding and, consequently,
catalysis. On the other hand, the S140A mutant protein
could bind NADPH (Figure 1), and fitting the data to a
hyperbolic function yielded an overall dissociation con-
stant (Kd) value of 26 (± 9) μM. This result suggests that
S140 residue plays a role in catalysis. This result also
demonstrates that the loss of enzyme activity of mutant
protein is not due to gross structural changes.
Molecular modeling
Several attempts to obtain crystals for S140T and S140A
MabA proteins were unsuccessful in our hands. Accord-
ingly, to try to interpret the steady-state kinetics mea-
surements and fluorescence spectroscopy results at a
molecular level, bioinformatics tools were used. Hom-
ology modeling is based on the assumption that tertiary
structures of two proteins will be similar if their
sequences were related, and it is the approach most
likely to give accurate results [23]. The homology models
for S140T and S140A mutants in complex with NADPH
were obtained using the coordinates of WT InhA asFigure 1 Fluorescence spectroscopy of equilibrium binding of NADPH
nucleotide fluorescence upon NADPH binding to S140A mutant. Inset: NADtemplate (PDB ID 1UZN) and the restrained-based mod-
eling implemented in the Modeler 9v5 program [24]. A
total of 1000 models were generated and the final mod-
els were selected based on the objective function
obtained from Modeler 9v5 [24]. The selected models
were submitted to energy minimization in water,
employing the GROMACS [25] package using Gromos
96.1 (53A6) force field [26] to make the analysis between
protein and NADPH more realistic. Each structure was
placed in the center of a truncated cubic box filled with
Extended Simple Point Charge (SPC/E) water molecules
[27], and the protein solvated by a layer of water mole-
cules of at least 10 Å in all directions in both systems.
The binary complex and water molecules were subjected
to 1500 steps of energy minimization by conjugate gradi-
ent to remove close van der Waals contacts, and the
overall stereochemical quality of the final models was
assessed by the program PROCHECK [28]. Analysis of
the Ramachandran diagram Φ-ψ plots indicated that all
models had over 95% of the residues in the most favor-
able regions.
The specificity and affinity between enzyme and its
substrate depend on directional hydrogen bonds and
ionic interactions, as well as on shape complementarity
of the contact surfaces of both partners [29,30]. Analysis
of the hydrogen bonds between either WT, S140T, or
S140A MabA protein and NADPH (Table 1) reveals, re-
spectively, sixteen (Figure 2), twelve (Figure 3), and ten
(Figure 4) intermolecular hydrogen bonds. The WT
MabA, S140A and S140T models are shown superim-
posed in Figure 5. The hydrogen bonds were calculated
by LIGPLOT program [31] with a 3.5 Å cutoff. The
XSCORE [32], LigScore [33], and Drugstore [34]to MabA mutant proteins. Dependence of the enhancement in
PH titration of S140T mutant protein.
Table 1 Hydrogen bonds between amino acid residues and NADPH for WT, S140A and S140T MabA proteins
Hydrogen bond Hydrophobic contact
Protein Residues Atoms Distance (Å) Residues
MtMabAWT Gly22 O!O3B 2.9 Pro183















MtMabAS140A Gly22 O!O3B 2.9 Asp61
Asn24 OD1!O3B 2.9 Pro183








MtMabAS140T Gly22 O!O3B 3.0 Asp61
Asn24 OD1!O3B 3.0 Arg25
Ile27 N!O2N 3.1 Ala89
Val62 N!N1A 2.8 Pro183








Rosado et al. BMC Research Notes 2012, 5:526 Page 4 of 10
http://www.biomedcentral.com/1756-0500/5/526programs were employed to evaluate the binding affinity
of NADPH for WT and mutant MabA proteins. The
computational predictions for pKd (-logKd) values for
WT MabA, S140A and S140T mutants for NADPH bin-
ary complex formation are given in Table 2.Discussion
Although a component of the Ser-Tyr-Lys catalytic triad
has been proposed to play a role in either catalysis and/or
binding based on the dependence of WT MabA enzyme
activity on various pH values [17], there has been no
Figure 2 LIGPLOT diagram for WT MabA and NADPH binary complex. Covalent bonds of NADPH are in purple, covalent bonds of amino
acids in light brown, hydrogen bonds are in green dashed lines. Protein residues in hydrophobic contacts with NADPH are represented by red
semi-circles with radiating spokes. There are sixteen hydrogen bonds between WT MabA and NADPH.
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sign any role to the S140 residue of MabA. Pre-steady
state kinetics of WT MabA: NADPH binary complex for-
mation has shown that there are two forms of free WTMabA in equilibrium in solution with different affinity for
NADPH [20], consistent with the symmetry model [35].
Equilibrium NADPH binding to WT MabA was shown to
display strong positive homotropic cooperativity, with
Figure 3 LIGPLOT for S140T MabA mutant and NADPH binary complex. Colour-coded bonds and intermolecular interactions are as for
Figure 2. There are twelve hydrogen bonds between S140T MabA and NADPH.
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NADPH:WT MabA binary complex formation, and 2 for
h, the Hill coefficient [20]. This Hill coefficient value is the
upper limit for dimeric proteins, indicating complete posi-
tive cooperativity. An assumption of all-or-none (as in thesymmetry model) is implicit in the Hill equation [36]. Ac-
cordingly, in the simplest case of strong positive homotro-
pic cooperativity, an estimate for the intrinsic dissociation
constant of NADPH binding to WT MabA (considering
K = K1K2) would have a value of 6.86 μM. The predicted
Figure 4 LIGPLOT for S140A MabA mutant and NADPH binary complex. Colour-coded bonds and intermolecular interactions are as for
Figure 2. There are ten hydrogen bonds between S140A MabA and NADPH.
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Figure 5 The NADPH binding sites of WT MabA, S140A and S140T models are shown superimposed. The structures are represented in
stick model. WT MabA (light gray), S140A (red), and S140T (blue).
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troscopy data, showing that larger pKd values correspond
to lower dissociation constant values for binary complex
formation. It should be pointed out that even though the
pKd values estimated by the XSCORE [32], LigScore [33]
and Drugstore [34] programs are different, they all show
the same trend in overall dissociation constants for binary
complex formation (Table 2). In addition, pKd values do
not give a good prediction of the experimental Kd values.
There have been numerous reports showing that the
central acid–base catalyst in SDRs is a Tyr group that
donates or abstracts a proton to/from the substrate [16].
To function as a base, tyrosine must be ionized (tyrosi-
nate). However, the normal pKa of Tyr is 10.2, which
would make it difficult to ionize in neutral solutions. In
the active site of SDR proteins, the pKa of Tyr is lowered
by approximately four pH units by the positive electro-
static field created by a conserved Lys and the quaternaryTable 2 XSCORE, DrugScore and LigScore evaluation
upon binary complex formation
XSCOREa DrugScore LigScore
MabAWT 7.15 -139 -14,57
MabAS140A 7.06 -136 -12,18
MabAS140T 6.10 -119 -9,30
a Given in units of pKd.nitrogen of oxidized, charged cofactor nicotinamide. The
Lys E-amino group is also involved in nicotinamide ri-
bose binding. However, pH-dependence of WT MabA
kinetic parameters indicated that a single enzyme group
with pKa value of 9.6 abolishes activity upon deprotona-
tion [17]. This pKa value, as pointed out above, prompted
the authors to suggest that either Tyr or Lys of MabA
catalytic triad plays a role in catalysis and/or substrate
binding. These results underscore the need to present ex-
perimental data to support a predicted role to any amino
acid residue, since there appears to be no need to lower
the pKa value of catalytic Tyr side chain of MabA. A con-
served active site Asn residue and its main chain car-
bonyl group interacts with a water molecule that is in H-
bonding distance to the active site Lys, thereby establish-
ing a proton relay system connecting bulk solvent to the
active site Tyr residue in SDR proteins [37]. Site-directed
mutagenesis of Ser138 residue of the Gram-negative bac-
terium Comamonas testosteroni 3β/17β-hydroxysteroid
dehydrogenase (3β/17β-HSD) protein, an SDR family
member, has shown that S138A mutation resulted in
complete loss of activity, whereas S138T mutant had
steady-state kinetic parameters comparable to WT 3β/
17β-HSD enzyme [38]. Based on these results, it was pro-
posed that the hydroxyl group of S138 side chain is es-
sential for catalytic activity, playing a role in stabilization
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bonding to the hydroxyl group of the conserved Tyr [38].
These authors have also pointed out that “it is not clear
why in all SDR sequences thus far characterized Thr is
conspicuously absent at this position, since our in vitro
replacement of Ser138 with Thr yielded an active protein
with identical catalytic constants”. However, here we
show that the MabA S140T mutant has impaired
NADPH binding and no enzyme activity could be
detected, suggesting that, contrary to 3β/17β-HSD, Thr
cannot replace Ser140 in MabA. It is tempting to suggest
that impaired NADPH binding of S140T mutant as com-
pared to WT and S140A MabA proteins is due to the
bulkier side chain of threonine, which is borne out by the
weaker intermolecular contact between NADPH and en-
zyme binding site (Figure 5). Although the S140A mutant
is able to bind NADPH, this mutation results in inactive
MabA enzyme. Accordingly, these results point to S140
residue of MabA as a residue whose main role appears to
be in catalysis, in agreement with S138 of the catalytic
triad of Drosophila alcohol dehydrogenase, also an SDR
protein [18]. Notwithstanding, the S140 side chain may
also play an indirect role in NADPH binding as the
S140T showed impaired dinucleotide binding, in agree-
ment with both the MabA: NADPH (Figures 2, 3, 4 and
5) and MabA:cofactor: substrate molecular models [39].
Interestingly, a conspicuous consequence of replacing
S140 with threonine (Figure 3) or alanine (Figure 4) is on
Lys157 which is no longer within the 3.5 Å cutoff for
hydrogen bonding distance. Accordingly, the S140 resi-
due appears to anchor the Lys157 catalytic triad of
MabA. On the other hand, the S140 residue appears to
have no effect on the Tyr153 of the catalytic triad of
MabA. It has been proposed that a switch from “closed”
to “open” conformation of MabA upon NADPH binding
brings the phenol ring of catalytic Tyr153 side chain to
the active site and that Ser140 induces this rearrange-
ment [38]. However, we have recently shown that there
are two forms of MabA in solution that differ in affinity
for NADPH [20], which could imply that the “open” and
“closed” conformations exist in equilibrium prior to
NADPH binding. Interestingly, although tetrameric
β-ketoacyl Reductase from Escherichia coli [40], Plasmo-
dium falciparum [41] and Brassica napus [42] display
negative homotropic cooperativity; β-ketoacyl Reductase
from M. tuberculosis (MabA) [20] and Staphylococcus aur-
eus [43] exhibit positive homotropic cooperativity. Unfor-
tunately, attempts to obtain crystals of S140T and S140A
MabA mutants have been unsuccessful in our hands.
Conclusions
The S140 side chain appears to play a role in MabA ca-
talysis that is likely not lowering the pKa value of
Tyr153. Interestingly, there was a shift from sigmoidalfor WT MabA [20] to hyperbolic for S140A (Figure 1)
titration curve upon NADPH binding. This finding sug-
gests that the S140 residue may play a role in displacing
the pre-existing equilibrium between two forms of
MabA in solution, thereby affecting enzyme activity.
Nina M. Goodey and Stephen J. Benkovic have pointed
out that chemical compounds that can shift the equilib-
rium to protein conformers with lower substrate affinity
and/or less catalytically competent must also be consid-
ered in drug design [44]. Ideally though, the crystal
structure of S140A mutant protein should be obtained
to shed further light on the role of this residue in MabA.
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